News Room

Envisioning New Horizons in Ocular Drug Delivery

In this article, Jay S Duker, MD, Chief Operating Officer at EyePoint Pharmaceuticals, discusses the history and future of ocular drug delivery, with a special focus on posterior segment diseases and the battle to overcome significant patient and caregiver burdens.